INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.

Medical Freedom Maps

Home » Maps » Right to try » Montana

Right to try in Montana

Right to try laws and requirements in Montana. Citations, verification dates, and source links for every data point.

DimensionValueCitationSourceVerifiedConfidence
Have Enacted State Right to Try Lawshave state RTT lawsMont. Code Ann. §§ 50-12-101 to 50-12-110 (Right to Try Act)“"Experimental treatment" means the provision of a medical intervention by a health care provider involving an investigational drug, biological product, device, or other treatment that has successfully completed phase 1 of a clinical trial”Link2026-10-09high
Enacted Right to Try Laws Before Federal Law2015Mont. Laws 2015, ch. 135“En. Sec. 1, Ch. 135, L. 2015.”Note: Enacted 2015 (Ch. 135, L. 2015), not 2017. RAPS's June 2015 tracker also listed Montana as 'Signed Into Law'.Link2026-10-09high
Require Individualized Manufacturer Approval for RTTdo not require individualized approval sources differMont. Code Ann. §§ 50-12-102, 50-12-104 (as amended by Ch. 413, L. 2023; Ch. 621, L. 2025)“A patient is eligible for an experimental treatment if the patient has: (1) evaluated other treatment options currently approved by the United States food and drug administration”Note: Montana is on the brief's lead list of RTT 2.0 states. In 2023 (SB 422, Ch. 413) it broadened its RTT Act to non-terminal patients, and in 2025 (Ch. 621) it added experimental treatment centers. But the current MCA Title 50 ch. 12 part 1 (101-110) contains no 'individualized investigational treatment' definition or patient-specific (genetic-profile) pathway. 'Experimental treatment' still requires completion of phase 1. Part 2 is palliative care. So Montana's law does not match the Goldwater individualized-treatment model (best value FALSE), although trackers may count the 2023 expansion as RTT 2.0. Stored TRUE kept as a possible alternative; needs human review.Link2026-10-09medium
Provide Manufacturer Liability Protection Under RTTprovide liability shieldMont. Code Ann. § 50-12-110“A manufacturer of an investigational drug, biological product, or device, a pharmacist, a health care facility, a health care provider, or a person or entity involved in the care of a patient”Link2026-10-09high
Require Insurer Coverage of Investigational Treatmentsdo not require coverageMont. Code Ann. § 50-12-106“A health plan, third-party administrator, or governmental agency may provide coverage for the cost of an experimental treatment or the cost of services related to the provision of an experimental treatment under this part.”Link2026-10-09high

View full Montana profile (all layers) · Report an error on this page

Methodology: every value was checked in October 2026 against a specific source (statute, regulator or official list, or a named tracker page), and each links to that page with a short quote. Values no source could support are shown as “Not verified”. Verification was AI-assisted and spot-checked; laws change, so confirm with the linked source before relying on a value. How values are verified · Report an error.